Edition:
United States

Vital Therapies Inc (VTL.OQ)

VTL.OQ on NASDAQ Stock Exchange Global Select Market

0.33USD
20 Sep 2018
Change (% chg)

$-0.00 (-0.54%)
Prev Close
$0.33
Open
$0.34
Day's High
$0.35
Day's Low
$0.30
Volume
1,237,846
Avg. Vol
336,270
52-wk High
$9.70
52-wk Low
$0.25

Latest Key Developments (Source: Significant Developments)

Muneer Satter To Sell All Of Stock Owned In Vital Therapies
Tuesday, 18 Sep 2018 06:35am EDT 

Sept 18 (Reuters) - Vital Therapies Inc ::MUNEER SATTER SAYS SINCE VITAL THERAPIES TO CEASE DEVELOPMENT OF ELAD SYSTEM, EXPLORE STRATEGIC OPTIONS SATTER TO SELL ALL OF STOCK OWNED.MUNEER SATTER REPORTS 0.51 PERCENT STAKE IN VITAL THERAPIES AS OF SEPT. 13 - SEC FILING.MUNEER SATTER PREVIOUSLY REPORTED 27.2 PERCENT STAKE IN VITAL THERAPIES AS OF MAY 25.  Full Article

Vital Therapies Began Notifying 85 Employees On Sept 14
Friday, 14 Sep 2018 06:11am EDT 

Sept 14 (Reuters) - Vital Therapies Inc ::VITAL THERAPIES - CO BEGAN NOTIFYING ABOUT 85 EMPLOYEES WHOSE EMPLOYMENT TO BE TERMINATED ON SEPT 14, 2018 - SEC FILING.VITAL THERAPIES INC SAYS ESTIMATES TO INCUR PRE-TAX CASH CHARGES OF $2-$2.5 MILLION FOR SEVERANCE PAY EXPENSES AND RELATED CASH EXPENDITURES.VITAL THERAPIES INC SAYS EXPECTS TO RECOGNIZE THE MAJORITY OF THESE CHARGES IN THE THIRD QUARTER OF 2018.VITAL THERAPIES-THE EMPLOYEE NOTIFICATION WAS IN CONSISTENT WITH CO'S DECISION TO CEASE ANY FURTHER DEVELOPMENT OF ELAD(REG) SYSTEM, ON SEPT 13, 2018.  Full Article

Vital Therapies Files For Up To $200 Million Mixed Shelf
Friday, 25 May 2018 04:32pm EDT 

May 25 (Reuters) - Vital Therapies Inc ::VITAL THERAPIES FILES FOR UP TO $200 MILLION MIXED SHELF - SEC FILING.VITAL THERAPIES ALSO FILES FOR SECONDARY OFFERING OF UP TO 2.5 MILLION SHARES OFFERED BY SELLING STOCKHOLDERS.VITAL THERAPIES - SELLING STOCKHOLDERS MAY FROM TIME TO TIME, AFTER CO ANNOUNCES TOPLINE DATA FOR VTL-308 CLINICAL STUDY, OFFER UP TO 2.5 MILLION SHARES.  Full Article

Vital Therapies Q1 Loss Per Share $0.34
Tuesday, 8 May 2018 04:01pm EDT 

May 8 (Reuters) - Vital Therapies Inc ::VITAL THERAPIES ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.34.Q1 EARNINGS PER SHARE VIEW $-0.34 -- THOMSON REUTERS I/B/E/S.  Full Article

Vital Therapies Announces Q4 Loss Per Share $0.35
Tuesday, 13 Mar 2018 04:01pm EDT 

March 13 (Reuters) - Vital Therapies Inc ::VITAL THERAPIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.35.Q4 EARNINGS PER SHARE VIEW $-0.31 -- THOMSON REUTERS I/B/E/S.BELIEVES ITS CURRENT CASH POSITION SHOULD PROVIDE FUNDING THROUGH Q1 OF 2019​.  Full Article

Vital Therapies Appoints Russell J. Cox As Chief Executive Officer And Board Member
Monday, 4 Dec 2017 04:29pm EST 

Dec 4 (Reuters) - Vital Therapies Inc ::VITAL THERAPIES APPOINTS RUSSELL J. COX AS CHIEF EXECUTIVE OFFICER AND BOARD MEMBER EFFECTIVE JANUARY 3, 2018.VITAL THERAPIES INC - COX WILL SUCCEED TERRY WINTERS.  Full Article

Vital Therapies reports Q3 loss per share $0.30
Wednesday, 25 Oct 2017 04:01pm EDT 

Oct 25 (Reuters) - Vital Therapies Inc ::Vital therapies announces third quarter 2017 financial results.Q3 loss per share $0.30.Q3 earnings per share view $-0.32 -- Thomson Reuters I/B/E/S.Vital Therapies-believes current cash position could provide funding through q1 2019, past expected announcement of VTL-308 top-line trial results​.  Full Article

Vital Therapies Q2 loss per share $0.29
Thursday, 3 Aug 2017 04:01pm EDT 

Aug 3 (Reuters) - Vital Therapies Inc ::Vital Therapies announces second quarter 2017 financial results.Q2 loss per share $0.29.Q2 earnings per share view $-0.35 -- Thomson Reuters I/B/E/S.Vital Therapies Inc - research and development expenses increased to $9.8 million for three months ended June 30 versus $6.9 million for 3 months ended June 30, 2016​.  Full Article

Vital Therapies announces Q1 loss per share $0.39
Tuesday, 9 May 2017 04:01pm EDT 

May 9 (Reuters) - Vital Therapies Inc :Vital Therapies announces first quarter 2017 financial results.Q1 loss per share $0.39.Q1 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S.  Full Article

Vital Therapies announces exercise in full of underwriters' option to purchase additional shares of common stock in public offering
Wednesday, 29 Mar 2017 04:01pm EDT 

Vital Therapies Inc : Vital Therapies announces exercise in full of underwriters’ option to purchase additional shares of common stock in public offering . Vital Therapies Inc - underwriters have exercised in full their option to purchase an additional 1.3 million shares of its common stock .Vital Therapies Inc - Vital Therapies currently plans to use net proceeds from this offering for continuing clinical development of ELAD system.  Full Article

Vital Therapies shares dive as liver system fails trial

U.S. biotech firm Vital Therapies Inc said it will explore strategic options after its liver disease treatment failed to meet the main goal of a late-stage study, driving its shares down more than 70 percent on Wednesday.